Dr. Raphael I. Kieval, MD

Dr. Kieval practices at Rheumatology Consultants in Brockton, Massachusetts.

Dr. Kieval's NPI, 1730155029, was assigned on February 27, 2006. Dr. Kieval graduated from Boston University School Of Medicine in 1982. Dr. Kieval's Massachusetts license number on file is 52349.

Dr. Kieval's primary practice is Rheumatology Consultants, at 1351 Main St, Brockton, MA 02301. The practice phone is (508) 587-4112.

Dr. Kieval's primary practice is Rheumatology Consultants in Brockton, Massachusetts. Dr. Kieval is also affiliated with Signature Healthcare Brockton Hospital. The medical group on file is Boston Medical Center (BMC). Dmand AI also links Dr. Kieval to 4 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kieval practices, 9 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Kieval's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Kieval is board certified in internal medicine by the American Board of Internal Medicine. Dr. Kieval has a license on file in Massachusetts.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, lupus, muscle pain, fibromyalgia, and limb pain, osteoporosis and rheumatoid arthritis among the conditions Dr. Kieval treats.

CMS data shows 150,746 Medicare services from Dr. Kieval across 27 procedure codes in 2024, for 885 Medicare patients. Medicare paid $1,542,356 for them. Every service was in an office.

CMS counts 885 Medicare patients who saw Dr. Kieval in 2024. The largest group is 65 to 74, with 362 patients. 75% of them have arthritis, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kieval's median patient age at 65, with 72% women.

In 2024, Dr. Kieval wrote 9,907 Medicare Part D claims for 1,039 patients. 88% of them were for generic drugs. CMS names the drug for 9,666 of them, across 81 drugs with 11 or more claims each, at $6,355,637 in total drug cost. In 2023, CMS named 9,910 claims across 82 drugs.

Dr. Kieval accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kieval as offering telehealth.

Dmand AI links 6 papers to Dr. Kieval. Dr. Kieval has published most often in Arthritis Rheum.

CMS Open Payments shows 2,533 general payments to Dr. Kieval from 55 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Abbvie Inc. paid the most, $90,941.

Dmand AI lists 2 awards for Dr. Kieval, most recently CMS Stage 1 EHR in 2013. Dr. Kieval serves on P&T.

Dr. Kieval graduated from Boston University School Of Medicine in 1982. Dr. Kieval is a member of ACR.

Dr. Kieval is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.